Mild telomerase reverse transcriptase (TERT) activation and telomere stabilization
Telomerase (TERT) Activation & Telomere Protection · Epigenetics and one-carbon methylation
Moderately promotes TERT gene transcription or activates the catalytic subunit of telomerase, slowing telomere shortening during replicative aging of hematopoietic stem cells, immune T and B cells, and vascular endothelial cells.
Why it matters: A key molecular lever for maintaining the long-term proliferative capacity of the immune system and protecting stem cell reserves from depletion. Activation must be kept strictly within the physiological range to prevent abnormal tissue proliferation.
Supplements acting on this mechanism (ranked by strength and evidence)
Cycloastragenol (TA-65)
Animal and cell studies suggest that cycloastragenol can affect TERT-related telomerase expression. In human randomized trials, mean telomere length in blood cells increased in the low-dose group, while the high-dose group did not reach statistical significance. Telomerase activity at 12 months did not differ significantly between groups, so telomerase activation in humans has not been established.